OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Psychoactive Drugs is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–2020	35
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool	23
Pathways to Peer Support in Sober Living Houses: The Importance of Social Model Environments and Helping Behaviors	20
Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence	16
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey	16
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health	16
Methamphetamine-Induced Wakefulness and Sleep Management: A Qualitative Analysis of Online Narratives	16
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies	16
Construction and Standardization of Perceived Shame Scale for Young Adults with Paternal Substance Use Disorder in Pakistan	14
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers	14
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency	13
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders	13
The Epidemiology of Psychedelic Use Among United States Military Veterans	13
Religion, Psychedelics, Risky Behavior, and Violence	13
Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine	12
“It’s so Natural It Goes Hand in Hand”: A Qualitative Study of Maternal Perceptions of Cannabis Use during Pregnancy	12
Selection Bias in Psychedelic Research: Comparing Self-Reported Quality-Of-Life Impact Between Enthusiasts and a General Population Sample	12
Suicide Attempts in an Italian Population with Cannabis Use Disorders: Results of a Follow-Up Study	12
Prescription and Non-Prescription Anxiolytic Use is Linked to Personal Characteristics Among University Students	11
Religious Social Integration, Psychedelics, and Psychological Distress	11
Naturalistic Psychedelic Use: A World Apart from Clinical Care	11
A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients’ Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand	10
Comparison of Emotional Processing Between Patients with Substance Use Disorder and Those with Dual Diagnosis: Relationship with Severity of Dependence and Use During Treatment	10
From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics?	10
Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms	10

Role Strain Among Parents Who are Medical Cannabis Patients in Pennsylvania	9
Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context	9
Psychedelic Microdosing among Young Adults from Southern California	9
Self-Forgiveness and Gratitude in Recovery from Substance Use Disorders	9
Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment	9
Interactions Between Depressive Symptoms, Childhood Trauma, and Drug Craving in Chinese Men with Methamphetamine Use Disorder: A Network Analysis	9
Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use	9
Effect of Social Vulnerability on Cocaine-Related Mortality Rates in U.S. Counties	9
Psychedelic Use and Behavioral Addictions	8
Solitary Cannabis Use and Related Consequences Among College Students During the COVID-19 Pandemic	8
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use	8
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials	8
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge	8
The Relationship Between Alcohol Use, Blood Alcohol Concentration, and Road Traffic Accidents: A Scoping Review	8
Cortisol/DHEA-S Ratio Normalization by Buprenorphine: Associations with Stress, Coping, and Social Support in Youth with Opioid Use Disorder	8
Minor Cannabinoid Use Among Medical Cannabis Patients	8
Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression – A Systematic Review	8
State-Level Support for Recovery Housing: Results from a National Collaborative Study of U.S. Single State Agencies	7
Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress	7
Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study	7
The Protective Role of Savoring on Coping Motives for Cannabis Use and Consequences	7
Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes	7
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study	7
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset	7
N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)	7
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences	6
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals	6
Cannabis Expectancies for Sleep Modulate Discrepancies Between Subjective and Objective Sleep Outcomes: A Pilot Study	6
Kratom Retail Availability in Fort Worth, Texas	6
Examining Volunteer Bias in Psychedelic Research	6
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy	6
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products	6
Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT)	6
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review	6
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?	6
Outcomes Among Sober Living House Residents Who Relapse: Role of Recovery Capital	6
Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program	6
MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials	5
Public Knowledge, Perceptions, and Behavioral Intention Regarding Medical Cannabis in Belgium	5
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption	5
Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review	5
Approach Without Liking: The Effects of Smoking-Related Settings on Implicit Liking Attitudes and Approach Tendencies Toward Smoking	5
Death Anxiety Among Users and Non-Users of Psychedelics	5
Identification of Cannabis Product Characteristics and Pricing on Dark Web Markets	5
What Differentiates Dropping Out from Remaining in a Brief Intervention for Problematic and Dependent Methamphetamine Users?	5
Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico	5
Cultural Adaptation of Overdose Education Programs: Recommendations from Black Americans with Lived Experience of Opioid and Stimulant Use	5
Driving Under the Influence of Alcohol, Cannabis, and Delta-8 THC: Perceived Likelihood, Risk Perceptions, and Behaviors	4
Cannabis Dependence Among Georgian Small-Scale Cannabis Growers: Results of a Cross-Sectional Online Survey	4
Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review	4

The Association of Substance Use Disorder (SUD) Type and Other Factors in SUD Recognition Among U.S. Adults	4
Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses	4
O-Know Opioid Knowledge Test: Development and Psychometric Testing in a Community Setting	4
The Complexity of Impulsivity Dimensions among Abstinent Individuals with Substance Use Disorders	4
Economic Stress, Mental Health, and Drug Use: Regional Insights from Taiwan	4
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts	4
Social Learning Theory and Gateway Hypothesis as a Causal Pathway Linking Rule-Breaking Peer Association to Marijuana Use via Nicotine Vaping	4
In Memoriam: Roland R. Griffiths (July 19, 1946–October 16, 2023)	4
How Personal Attitudes About Legalizing Cannabis and Corresponding State Laws Affect the Stigma of Cannabis Use	4
Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay	4
Pain Intensity and Hazardous Cannabis Use: The Moderating Role of Pain-related Anxiety	4
Sweating for Sobriety: Exploring the Relationship Between Exercise Engagement and Substance Use Disorders	4
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine	4
Prevalence of Substance Use Among Asian Sexual Minority Individuals in the United States, 2015-2020	4
“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics	4
Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts	4
Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States	4